Pyridostigmine bromide 180mg modified-release tablets now listed in Part VIIIA of Drug Tariff

Pyridostigmine bromide 180mg modified-release tablets now listed in Part VIIIA of Drug Tariff

November 27, 2017

Pyridostigmine bromide 180mg modified-release tablets entered the Drug Tariff Part VIIIA as a Category C line based on Mestinon retard in November 2017.

Please note that as this item is now listed in the Drug Tariff the way you endorse prescriptions for this line has changed.

No endorsement is needed unless you have been charged out of pocket expenses (OOP). To ensure correct payment for OOP, contractors must endorse:

  • ‘OOP’ or ‘XP’ for paper prescriptions;
  • ‘XP’ for electronic prescription submissions;
  • Details of the claim being made (e.g. postage and packaging); and
  • The total amount being claimed.

For more information on out of pocket expenses see our page here.



Posted in: ,


More Latest News >